Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival ...

in intermediate risk papillary thyroid cancer (PTC) and low risk, minimally invasive follicular thyroid cancer (FTC). A higher survival rate after undergoing radioiodine therapy begins to emerge ...

Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative ...

A link is identified between perinatal exposure to fine particulate air pollution and nighttime light, and the risk of ...

TAR-200 demonstrated a high disease-free survival and bladder preservation rates in BCG-unresponsive, high-risk ...

Lymph node metastasis was uncommon among clinically node-negative PTC patients without evidence of nodal involvement on USG and CT.

Ramos, MD, PhD, discusses findings from cohort 4 of the phase 2 SunRISe-1 trial of TAR-200 in patients with high-risk, ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The ongoing phase 2b SunRISe-1 study is assessing TAR-200 intravesical gemcitabine delivery in patients with BCG-unresponsive high-risk NMIBC.